SYNGAP1 Research Roadmap
Here are our introductory comments:
Dr. Rumbaugh gave a talk titled SYNGAP1 Research Roadmap on June 18th, 2020.
Dr. Gavin Rumbaugh is a neuroscientist at Scripps Research Institute doing research on SYNGAP1. In this webinar, he talks about how disrupted SYNGAP1 functions affect the way neurons connect and create networks, as well as the different variants of SYNGAP1 and what they mean when thinking about therapeutics for SYNGAP1 patients. He does a deep dive into the concept of genetic haploinsufficiency, the characteristic of patients having half as much SYNGAP1 flowing through their brain, being the root cause of 80% of SYNGAP1 patients’ brain disorders. He explains how this is an important concept when considering the different approaches for raising SYNGAP1 protein levels in the brain. Finally, he closes the webinar with the work his lab is doing to find pathways in the brain and compounds that could be used to raise SYNGAP1 expression.
Other Relevant Publications by Dr. Rumbaugh
Syngap1 regulates experience-dependent cortical ensemble plasticity by promoting in vivo excitatory synapse strengthening
SYNGAP1 Controls the Maturation of Dendrites, Synaptic Function, and Network Activity in Developing Human Neurons
Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders
You may also like
74 - COMBINEDBrain Biobank & Our Partnership with SRF for SYNGAP1
Terry Jo Bichell, PhD, MPH
68 - Harnessing Messenger RNA metabolism for the development of precision gene therapy - SYNGAP1
Jeff Coller, PhD
73 - Linking SYNGAP1 with Human-Specific Mechanisms of Neuronal Development
Pierre Vanderhaeghen, MD, PhD
VIB Center for Brain & Disease Research